Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Heart and Vessels
Published in: Heart and Vessels 3/2000

01-05-2000 | ORIGINAL ARTICLE

Optimal therapeutic range for oral anticoagulants in Japanese patients with prosthetic heart valves: a preliminary report from a single institution using conversion from thrombotest to PT-INR

Authors: Y. Uetsuka, Saichi Hosoda, Hiroshi Kasanuki, Masahiko Aosaki, Kagari Murasaki, Katsuyoshi Ooki, Miyuki Inoue, Etsuko Akiyama, Masukazu Kitada

Published in: Heart and Vessels | Issue 3/2000

Login to get access
Metadata
Title
Optimal therapeutic range for oral anticoagulants in Japanese patients with prosthetic heart valves: a preliminary report from a single institution using conversion from thrombotest to PT-INR
Authors
Y. Uetsuka
Saichi Hosoda
Hiroshi Kasanuki
Masahiko Aosaki
Kagari Murasaki
Katsuyoshi Ooki
Miyuki Inoue
Etsuko Akiyama
Masukazu Kitada
Publication date
01-05-2000
Publisher
Springer-Verlag
Published in
Heart and Vessels / Issue 3/2000
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/PL00007265

Other articles of this Issue 3/2000

Heart and Vessels 3/2000 Go to the issue

ORIGINAL ARTICLE

Myocardial ischemia enhances the expression of acidic fibroblast growth factor in human pericardial fluid

ORIGINAL ARTICLE

Hyperhomocyst(e)inemia induces multiorgan damage

ORIGINAL ARTICLE

Role of circulating vascular endothelial growth factor and hepatocyte growth factor in patients with coronary artery disease

CASE REPORT

Plasma brain natriuretic peptide as a parameter to assess efficacy of continuous intravenous infusion of prostacyclin (epoprostenol) to treat severe primary pulmonary hypertension: a case report

ORIGINAL ARTICLE

Does repeated balloon inflation during coronary angioplasty induce ischemic tolerance? Analysis based on regional work

ORIGINAL ARTICLE

Strategies for CABG patients with carotid artery disease and perioperative neurological complications

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits